Archives: Team Showcase

With over 35-years of experience in healthcare leadership, Javad has extensive experience in overall operations (product development,manufacturing and QA/RA) on a global scale, including North America, Europe, Latin America, and Asia.

Javad has held executive roles at Gambro , Toshiba Medical Systems, Bayer Healthcare, Siemens Healthcare, and NovaSignal and Nile.ai.

Javad’s business-oriented approach extends to product development and operational excellence. He has been instrumental in streamlining processes, reducing product costs, and implementing efficient organizational designs. His leadership has been crucial in driving product development strategies that align with regulatory compliance and market needs.

Andy Schultz is the Chief Commercial Officer of Kandu, Inc.  Previously, Andy was the  SVP of Revenue and Operations at Candid, a disruptor in the orthodontic clear aligner space.

Prior to Candid, Andy was the Vice President Customer Experience and Planning at Scotts Miracle-Gro. Over 13 years there he held various leadership roles in sales, operations, strategy and supply chain. Prior to that time, Andy was a First Officer for Northwest Airlink. He served 8 years in the US Navy aboard the USS Enterprise and as a part of the Blue Angels Flight Demonstration Squadron. Andy graduated from Embry-Riddle Aeronautical University.

Kirsten has over 20 years of experience in stroke with various leadership roles at Boston Scientific, Stryker, and Imperative Care. She was the Founder and Chief Executive Officer of Kandu Health and became the Chief Marketing Officer and General Manager of Clinical Services at the conclusion of the merger with Neurolutions in March 2025. Kirsten holds several patents in the fields of stroke treatment and detection, and she is the author of several peer-reviewed papers in the field of stroke and access to care.

Nabeel is the Chief Financial Officer of Kandu, Inc. Prior to joining Kandu, he was the Chief Financial Officer of Outset Medical, Inc., a medical dialysis technology company. Prior to Outset Medical, Nabeel held a variety of finance leadership roles, including as Vice President, Finance at 8×8, Inc., a communications platform provider, and at Vocera Communications, Inc., a provider of clinical workflow solutions. Previously, he held various leadership positions in accounting and finance, including as CFO of Wanderful Media as well as CFO of MarketTools, Inc. Earlier in his career, he served in positions of increasing responsibility at Ernst & Young, LLP and at eBay, Inc. Nabeel holds a Bachelor of Commerce degree from Laurentian University, and an M.B.A., from the Wharton School, University of Pennsylvania.

Dr. Leo Petrossian is the Chief Executive Officer of Kandu Inc., a neurotechnology company formed from the merger of Neurolutions and Kandu Health. He is a seasoned healthcare executive and entrepreneur with deep expertise in bringing transformative medical devices from early development to commercialization. Under his leadership, Neurolutions pioneered the IpsiHand®, the first FDA-cleared brain–computer interface for stroke rehabilitation. Dr. Petrossian is passionate about advancing technologies that expand access, improve outcomes, and reshape standards of care in neurology and beyond.

Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.